Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$520,526
-$116,251 QoQ
Shares Held
21,151
-20.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#280
of 515 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $116,746,250 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
915,683 | $101,585,870 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
32,222 | $5,430,695 | |
| 3 | ZTS |
Zoetis Inc.
|
58,581 | $4,209,630 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
44,770 | $3,706,060 | |
| 5 | HLN |
Haleon plc
|
79,244 | $739,346 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
21,151 | $520,526 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
19,930 | $357,942 | |
| 8 | VTRS |
Viatris Inc
|
12,354 | $196,181 |
All Filings in ELAN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,526 | 21,151 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $636,777 | 26,610 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,349,019 | 59,612 | Shares | Defined | 2026-02-13 | |
| 2021-06-30 | $200,299 | 5,774 | Shares | Defined | 2021-07-29 | |
| 2020-03-31 | $215,973 | 9,646 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||